Trends in Molecular Medicine

 


































































































Feedback

cell press
Journal Information
 

Audience
Trends in Molecular Medicine provides cutting edge authoritative perspectives on the latest breakthroughs in the multidisciplinary field of molecular medicine. Trends in Molecular Medicine keeps students and research professionals up to date with key developments, and provides a forum for discussion and debate among basic scientists and clinicians, with a view to facilitating progress in translational research. The audience comprises medical students, graduate students in the biomedical sciences, scientists (academic and industrial) and clinicians with an interest in understanding the molecular basis of disease and in using molecular biology to develop innovative approaches for the prevention, diagnosis and treatment of disease.


Instructions to Authors
Trends in Molecular Medicine is divided into three sections: Update, Opinion and Review. Articles are invited by the Editor, but proposals are welcome, especially for the Opinion section. Prospective authors should send a brief summary (up to 300 words), citing key references, to the Editor, who will supply guidelines on manuscript preparation if the proposal is accepted. The submission of completed manuscripts without prior consultation with the Editor is strongly discouraged. Authors should note that all articles are peer-reviewed and publication cannot be guaranteed.

Review and Opinion articles form the foundation of each monthly issue. Review articles are invited from leading researchers and provide objective overviews and insights on key recent developments in newly emerging or rapidly progressing fields. Opinion articles present a personal, authoritative viewpoint on a particular topic. They can cover timely controversial issues or debates, provide a new framework for, or interpretation of, an old problem or current issue, or speculate in depth on the implications of recently published research. All articles are peer reviewed and edited to ensure that they are timely, accurate, interesting and relevant to the audience of Trends in Molecular Medicine. Every effort is made to explain specialist terms and illustrate concepts and hypotheses.

The Update section includes topical features such as Letters and Research Focus articles:

  • Trends in Molecular Medicine welcomes correspondence. Letters on any topic of interest may be submitted to the Editor (at tmm@elsevier.com). The decision to publish rests with the Editor, and the author(s) of any article discussed in a Letter will normally be invited to reply. Letters may address topics raised in recent issues of the journal, or other matters of general interest to biomedical scientists. Appropriate topics include comments, questions and discussion on articles and topics covered by Trends in Molecular Medicine, new Internet resources, ethical and legal issues, regulatory issues, and business and financial issues. Please note that previously unpublished data or criticisms of work published elsewhere cannot be published.
  • Research Focus articles alert readers to recent primary papers that are important to biomedical researchers, are particularly innovative, likely to have significant clinical impact, or are controversial.

Editorial Board
S. Agrawal, Cambridge, USA
K. Alitalo, Helsinki, Finland
H. Blau, Stanford, USA
T. Cox, Cambridge, UK
K. Culver, East Hanover, USA
K. Davies, Oxford, UK
I. Dunham, Hinxton, UK
F. Gage, La Jolla, USA
D. Gordon, Manchester, UK
W. Günzburg, Vienna, Austria
D. Gurwitz, Tel Aviv, Israel
M.A. Liu, Emeryville, USA
K. Matsushima, Tokyo, Japan
A. McMichael, Oxford, UK
A. Papavassiliou, Athens, Greece
W. Petri, Charlottesville, USA
D. Rader, Philadelphia, USA
C. Soto, Galveston, USA
T. Soussi, Paris, France
G.C. Tsokos, Silver Spring, USA
L.-C. Tsui, Toronto, Canada
J. Uitto, Philadelphia, USA
S. Waxman, New Haven, USA


Abstracting/Indexing

Biochemistry & Biophysics Citation Index
CAB Abstracts International
Chemical Abstracts
Current Contents (Life Science)
Index Veterinarius
Medline/MEDLARS Online
Nucleic Acids Abstracts
SciSearch/Science Citation Index Expanded


Bibliographic Information

Commenced publication 1995
Volume 14
2008, 12 issues
ISSN: 1471-4914


Statement on publishing ethics
The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct.


Conflict of Interest Policy
The Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author’s work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict. For more information, please refer to: http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest


Copyright statement

© 2008 Elsevier Ltd. All rights reserved.
This journal and the individual contributions contained in it are protected under copyright by Elsevier Ltd, and the following terms and conditions apply to their use:


Photocopying
Single photocopies of single articles may be made for personal use as allowed by national copyright laws. Permission of the publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profit educational classroom use.
Elsevier Science Rights & Permissions Department
PO Box 800
Oxford
UK OX5 1DX
Tel:+44 (0) 1865 843830
Fax: +44 (0) 1865 853333
E-mail: permissions@elsevier.co.uk

You may also contact Global Rights directly through Elsevier's home page (http://www.elsevier.com), selecting first 'Customer Support', then 'Permissions', then 'Permissions Request Form'.

In the USA, users may clear permissions and make payments through the

Copyright Clearance Center Inc
222 Rosewood Drive
Danvers
MA 01923 USA
Tel: +1 (978) 750 8400
Fax: +1 (978) 750 4744

and in the UK through the

Copyright Licensing Agency Rapid Clearance Service (CLARCS)
90 Tottenham Court Road
London
UK W1P 0LP
Tel: +44 (0) 20 7631 5555
Fax: +44 (0) 20 7436 5500

Other countries may have a local reprographic rights agency for payments.


Derivative Works
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution.
Permission of the publisher is required for all other derivative works, including compilations and translations.


Electronic Storage or Usage
Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Science Rights & Permissions Department, at the mail, fax and e-mail addresses noted above.


Notice
No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.
Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.